Clinical Trial Update: ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) [Phase 2, Phase 3]

View source ↗

Summary

A completed phase 2/3 trial comparing electroconvulsive therapy (ECT) to ketamine for treatment-resistant depression, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Treatment-resistant Depression

Drugs mentioned

• Electroconvulsive therapy
• Ketamine (ketamine)

Snippet

Sponsor: Bo Hu | Conditions: Treatment Resistant Depression, Electroconvulsive Therapy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2023-08-09